<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The coexistence of a primary <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and a T-cell cutaneous non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is an extremely rare event, which has so far only been reported in a single instance in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>We describe herein an additional case in which the lymphoid disease was combined with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> at the time of its evolution into <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Both diseases were successfully treated with a regimen containing fludarabine </plain></SENT>
<SENT sid="3" pm="."><plain>We discuss possible pathogenetic mechanisms and suggest the use of nonalkylating drugs, such as fludarabine, for the treatment of this rare association of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> usually characterized by a very poor response to therapy </plain></SENT>
</text></document>